Captopril6.25–50 mgbid or tid Enalapril2.5–40 mgDaily ARBLosartan25–100 mgDaily Olmesartan20–40 mgDaily Valsartan80–320 mgDaily CCB; dihydropyridinesAmlodipine2.5–10 mgDaily Nifedipine30–90 mgDaily Felodipine2.5–10 mgDaily CCB; nondihydropyridinesVerapamil40–360 mgtid ...
Captopril, like other ACE inhibitors, is used to treat hypertension and congestive heart failure (CHF). It has been used primarily in dogs, but its use has declined. Captopril is the first ACE inhibitor available for clinical use, but has been replaced by other ACE inhibitors such as enalapri...
Another angiotensin-converting enzyme inhibitor, captopril, has been shown to causeagranulocytosisandbone marrowdepression, rarely in uncomplicated patients (incidence probably less than once per 10,000 exposures) but more frequently (incidence possibly as great as once per 1000 exposures) in patients ...
Another angiotensin-converting enzyme inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression, rarely in uncomplicated patients (incidence probably less than once per 10,000 exposures) but more frequently (incidence possibly as great as once per 1000 exposures) in pati...
Nat Genet 10:111–113 Fu YF, Xiong Y, Fu SH (2003) Captopril restores endothelium- dependent relaxation of rat aortic rings after exposure to homocysteine. J Cardiovasc Pharmacol 42:566–572 Harmon DL, Shields DC, Woodside JV, Mc Master D, Yarnell JW, Young IS, Peng K, Shane B, Evans...